MMP9 and neoplasm: The recruitment of immune cells to the tumour microenvironment stimulates the secretion of matrix metalloproteinase-9 (role in matrix degradation) to evade the host’s immune responses and induces angiogenesis [73], increasing cell-viability, metastasis, and ultimately creating favourable conditions to develop treatment resistance [74].